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1015-9584/Copyright ª 2015, Asian SuSummary Background/Objective: Pancreatic fistula (PF) is the most common and chal-
lenging complication after pancreaticoduodenectomy (PD). This meta-analysis aimed to eval-
uate the impact of pancreaticogastrostomy (PG) versus pancreaticojejunostomy (PJ) on
occurrences of postoperative PF.
Methods: A systematic literature search in the Medline, EMBASE, OVID, and Cochrane data-
bases was performed to identify all eligible randomized controlled trials (RCTs). Pooled esti-
mates were presented with 95% confidence intervals (CI).
Results: Six RCTs involving 1005 patients met the inclusion criteria. The incidence of PF [odds
ratio (OR) 0.58, 95% CI, 0.42e0.81; p Z 0.001], intra-abdominal abscess or collections (OR
0.43, 95% CI, 0.28e0.65; p < 0.001), and biliary fistula (OR 0.28, 95% CI, 0.11e0.74;
p Z 0.01) were found to be significantly lower in the PG group than in the PJ group. There
was no significant difference in overall morbidity, other complications, hospital mortality, or
length of hospital stay between the two groups.
Conclusion: The meta-analysis showed that PG following PD represents a safe procedure asso-
ciated with fewer PFs compared with PJ.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.eclare that they have no potential competing interests.
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As a result of recent improvements in surgical techniques
and perioperative care, pancreaticoduodenectomy (PD) has
been refined to be a safe operation with <5% perioperative
mortality at high-volume centers, however, the morbidity
rate remains as high as 20e50%.1 Pancreatic fistula (PF) is
the most devastating postoperative complication occurring
in 2.5e25% patients,2 and has become the main reason for
increased morbidity and mortality, prolonged length of
hospital stay, and increased medical costs.
After PD, pancreatic continuity can be restored by per-
forming either a pancreaticojejunostomy (PJ) or a pan-
creaticogastrostomy (PG). A recent published meta-
analysis3 of four randomized controlled trials (RCTs)4e7
showed no significant difference between the two surgical
modalities in terms of PF occurrence. By contrast, two
more recent large-scale RCTs8,9 reported that the PF rate
with PG was lower than that with PJ. In the light of these
conflicting findings, the present meta-analysis was
attempted to provide a more updated evaluation of the
effect of PG versus PJ with respect to the PF rate after PD.
2. Methods
The study was conducted following the Preferred Reporting
Items for Systematic Reviews and Meta- Analyses
(PRISMA).10
2.1. Study selection
Systematic literature searches in the Medline, EMBASE,
OVID, and Cochrane databases were performed to identify
published RCTs that compared the postoperative PF rate
with PG versus PJ after PD from database inception to
November 2013. The Medical Subject Heading (MeSH)
search terms were “PD,” “pancreaticojejunostomy”, and
“pancreaticogastrostomy”. Only studies on humans and in
the English language were considered for inclusion. Refer-
ence lists of all retrieved articles were manually searched
for additional studies.
2.2. Data extraction
Two reviewers (B.L. and L.W.) independently extracted the
following parameters from each study: first author, year of
publication, study population characteristics, number of
patients randomized with each procedure, and endpoints.
All relevant text, tables, and figures were reviewed for data
extraction.
2.3. Criteria for inclusion and exclusion
RCTs that compared PG and PJ in patients undergoing PD
for malignant and benign diseases of the pancreas and
periampullary region were included in this review. Exclu-
sion criteria were: animal studies, studies evaluating pa-
tients who underwent total pancreatectomy or central
pancreatectomy, studies evaluating patients who under-
went PD without immediate pancreatic anastomosis orduodenum-preserving pancreatectomy, and nonrandomized
observational clinical studies.
2.4. Assessment of methodological quality
The RCTs were scored using the Jadad composite scale11 in
which each study was evaluated by examining three fac-
tors: randomization, blinding, and withdrawals and drop-
outs reported within the study period. The quality scale
ranged from 0 points to 5 points, and a study with a score of
3 points was considered to be of high quality.
2.5. Endpoints
The primary endpoint was PF. PF was determined according
to the consensus definition proposed by the International
Study Group of Pancreatic Fistula (ISGPF),12 as the presence
of amylase-rich fluid (>3 times the upper limit of normal in
the serum) of any measurable volume on or after post-
operative Day 3. The severity of PF was classified into three
grades as follows: Grade A fistulas were transient and did
not require any intervention; Grade B fistulas required
adjustment to the clinical pathway but the patients were
clinically well; and Grade C fistulas often required opera-
tive intervention and were associated with sepsis or death.
Secondary endpoints included overall morbidity, other
complications, hospital mortality, and length of hospital
stay.
2.6. Statistical methods
Review Manager (RevMan) software 5.0 (Nordic Cochrane
Centre, Copenhagen, Denmark) was used to conduct all
analyses. Odds ratio (OR) and weighted mean differences
(WMD) were used for the analysis of continuous and
dichotomous variables, respectively. If the study provided
medians and interquartile ranges instead of means and
standard deviations (SDs), the means and SDs were imputed
according to the methods described by Hozo et al.13 Pooled
estimates were presented with 95% confidence intervals
(CI). Pooled effect was calculated using either the fixed
effects model or random effects model. Heterogeneity was
evaluated using I2, with values >50% indicating consider-
able heterogeneity. Publication bias was assessed visually
using a funnel plot, based on the results of PF.
3. Results
3.1. Eligible studies
We identified 1837 potentially relevant records. After
excluding studies that did not fulfill our inclusion criteria,
six articles were retrieved for inclusion (Fig. 1).4e9 The two
reviewers had 100% agreement in their reviews of the data
extraction.
A total of 1005 patients were included in the meta-
analysis: 503 in the PG group and 502 in the PJ group. Of the
six included studies, two were conducted in Spain,7,8 one in
the USA,4 one in Italy,5 one in France,6 and one in Belgium.9
The sample size of each study varied from 108 patients to
Figure 1 Study selection. RCT Z randomized controlled
trial.
PG versus PJ 157329 patients. The characteristics of the included studies are
shown in Table 1.4e9
There was a lack of uniformity in the definition of PF in
three RCTs4e6 before the international consensus of PF
definition was published. In the remaining three studies,7e9
PF was defined according to the ISGPF.123.2. Meta-analysis
Table 2 shows the results for the outcomes. All studies
provided information on the incidence of PF, which was
found to be significantly lower in the PG group than that in
the PJ group (OR 0.58, 95% CI, 0.42e0.81; p Z 0.001). InTable 1 Summary of studies included in the meta-analysis.
Reference (Year) Enrolment
interval
(Country)
Group No. of
patients
(M/F)
Age (y)
Yeo et al4
(1995)
1993e1995
(USA)
PG 73 (33/40) 61.5  1.
PJ 72 (38/34) 62.4  1.
Bassi et al5
(2005)
2002e2004
(Italy)
PG 69 (44/25) 59.3
PJ 82 (51/31) 55.5
Duffas et al6
(2005)
1995e1999
(France)
PG 81 (51/30) 58.2  11
PJ 68 (35/33) 58.6  12
Ferna´ndez-Cruz
et al7 (2008)
2005e2007
(Spain)
PG 53 (29/24) 63  13
PJ 55 (38/17) 63  14
Figueras
et al8 (2013)
2008e2012
(Spain)
PG 65 (44/21) 67 (35e8
PJ 58 (37/21) 65.5 (42e
Topal et al9 2013 2009e2012
(Belgium)
PG 162 (100/62) 67.0 (60.
PJ 167 (91/76) 66.1 (59.
CPD Z classical PD; ISGPF Z International Study Group
PG Z pancreaticogastrostomy; PJ Z pancreaticojejunostomy;
pancreaticoduodenectomy.three studies,7e9 PF was defined and graded according to
the recommendations of the ISGPF.13 Pooled analysis
showed both overall PF (OR 0.47, 95% CI, 0.31e0.71;
pZ 0.0003) and clinically significant PF (Grade B or C) (OR
0.29, 95% CI, 0.17e0.49; p Z 0.001) were less frequent in
the PG group. No significant heterogeneity was found be-
tween studies regarding these outcomes (Fig. 2).
Regarding secondary endpoints, intra-abdominal abscess
or collections (OR 0.43, 95% CI, 0.28e0.65; p < 0.001) and
biliary fistula (OR 0.28, 95% CI, 0.11e0.74; p Z 0.01) were
found to be significantly lower in the PG group than in the
PJ group (Fig. 3). By contrast, overall morbidity (OR 1.29,
95% CI, 0.67e2.48; p Z 0.49), delayed gastric emptying
(DGE) (OR 0.84, 95% CI, 0.40e1.78; p Z 0.66), hemorrhage
(OR 1.27, 95% CI, 0.81e1.79; p Z 0.29), wound infection
(OR 1.36, 95% CI, 0.62e2.98; p Z 0.44), reoperation (OR
0.87, 95% CI, 0.53e1.42; p Z 0.59), hospital mortality (OR
0.81, 95% CI, 0.41e1.60; p Z 0.55), and length of hospital
stay (WMD 1.46, 95% CI, 3.43e0.52; p Z 0.15), were
comparable between the two groups. No significant het-
erogeneity was found between studies regarding these
outcomes, except for DGE and length of hospital stay.
3.3. Publication bias
The funnel plot for the primary outcome (PF) was sym-
metric, indicating the absence of publication bias (Fig. 4).4. Discussion
PJ is the conventional predominant surgical modality for
restoring pancreaticoenteric continuity following PD.Type of PD
PPPD/CPD
Definition of PF Quality
score
7 60/13 Radiographically
documented leak or >50
mL drainage of amylase
rich fluid on or after POD10
4
4 59/13
66/3 Any clinical significant
output of fluid, rich in
amylase, confirmed by
fistulography
4
70/12
18/63 Radiologically documented
leak or fluid rich in amylase
(at least 4 times normal
serum values) >3 d
4
18/50
All PPPD ISGPF 4
All PPPD
0) 30/35 ISGPF 4
80) 28/30
6e73.5) 98/64 ISGPF 4
4e74.6) 102/65
of Pancreatic Fistula; PD Z pancreaticoduodenectomy;
POD Z postoperative day; PPPD Z pylorus-preserving
Table 2 Results of a meta-analysis.
Outcome of interest No. of studies No. of patients OR/WMD 95% CI p I2 (%)
PF 6 1005 0.58 0.42, 0.81 0.001 1
ISGPF PF 3 560 0.47 0.31, 0.71 <0.001 0
ISGPF B þ C PF 3 560 0.29 0.17, 0.49 <0.001 0
Overall morbidity 6 1005 1.29 0.67, 2.48 0.49 32
Delayed gastric emptying 5 856 0.84 0.40, 1.78 0.66 66
Intra-abdominal abscess or collection 6 1005 0.43 0.28, 0.65 <0.001 0
Biliary fistula 5 676 0.28 0.11, 0.74 0.01 9
Hemorrhage 5 860 1.27 0.81, 1.79 0.29 0
Wound infection 2 253 1.36 0.62, 2.98 0.44 0
Reoperation 4 737 0.87 0.53, 1.42 0.59 0
Mortality 6 1005 0.81 0.41, 1.60 0.55 0
Length of hospital stay (d) 5 854 1.46 3.43, 0.52 0.15 96
CI Z confidence interval; ISGPF Z International Study Group of Pancreatic Fistula; OR Z odds ratio; PF Z pancreatic fistula;
WMD Z weighted mean difference.
158 Y. Zhou et al.Despite the many technical variations tested including the
anastomosis site of the jejunum used (end vs. side), type of
anastomosis (duct-to-mucosa vs. invagination), Peng’s
binding technique, using an isolated Roux-en-Y limb, and
use of fibrin glue and internal or external pancreatic duct
stenting,14 no universal consensus has been reached
regarding the safest technique of PJ that is less prone to
fistula formation.
PG was initially described by Waugh and Clagett15 in
1946 as an alternative to PJ anastomosis, and has gained
favor in recent years. A previous meta-analysis3 of fourFigure 2 Results of the meta-analysis on primary endpoints. (A) P
significant pancreatic fistula (ISGPF grade B þC). CI Z confidence
ISGPF Z International Study Group of Pancreatic Fistula.RCTs4e7 reported that there was no significant difference
between PG and PJ in terms of PF, probably because of the
small number of patients (n Z 553) enrolled in that meta-
analysis. It is generally believed that the power of a meta-
analysis to detect a possible treatment effect increases
with the increase in the number of patients enrolled. The
present updated meta-analysis that pooled six RCTs
involving a total of 1005 participants seems to conclude
that PG is associated with less PF compared with PJ. The
major strength of the present meta-analysis is that all the
included studies had a Jadad score of 4. It has beenancreatic fistula; (B) ISGPF pancreatic fistula; and (C) clinically
interval; df Z degrees of freedom, M-H Z Mantel-Haenszel;
Figure 3 Results of the meta-analysis on secondary endpoints. (A) Intra-abdominal abscess or collections; and (B) biliary fistula.
CI Z confidence interval; df Z degrees of freedom, M-H Z Mantel-Haenszel.
PG versus PJ 159suggested that inadequate generation of the allocation
sequence, allocation concealment, and double blinding
lead to exaggerated estimates of the intervention benefit
and may contribute to discrepancies between the results of
RCTs in meta-analyses.16 Another strength is that there is
no significant heterogeneity or publication bias regarding
the primary outcome (PF).
The description of PF varies greatly in the pancreatic
surgical literature. In 2005, the ISGPF proposed a stan-
dardized definition of DGE.12 Three of the six RCTs used the
ISGPF criteria and consistently found that the rate and
severity of PF was significantly lower with the PG technique
compared with that following PJ.7e9 The pooled data are
also in concordance with these RCTs.
There are several theoretical advantages that appar-
ently contribute to the low PF rate of PG. Pancreatic en-
zymes can be inactivated by gastric acid. However, as the
stomach does not contain enterokinase, it needs to beFigure 4 Funnel plot analysis of publication bias. The
outcome was the pancreatic fistula. OR Z odds ratio; SE(log
[OR]) Z standard error (log[OR]).converted from trypsinogen to trypsin to activate other
proteolytic enzymes. This lack of enzyme activation may
help prevent autodigestion of the anastomosis. In addition,
alkaline pancreatic secretions may help prevent marginal
ulceration. As the pancreas is in close proximity to the
posterior wall of the stomach, potentially less tension is
produced on the anastomosis. The abundant blood supply
to the stomach wall facilitates anastomotic healing, and
the thick stomach wall can hold sutures securely. Naso-
gastric decompression allows for continuous emptying of
the stomach, thus producing less tension on the anasto-
mosis. This benefit with PG is unmatched by PJ
anastomosis.17
Our meta-analysis also showed that the occurrence of
biliary fistula was significantly lower in the PG group. This
difference might be related to the fact that reconstruc-
tion by PG can shunt the flow of pancreatic juice and bile,
thus decreasing the pressure of tension at biliary anasto-
mosis. It is also possible that the lower occurrence of
pancreatic and biliary fistulas in the PG group is associated
with the lower incidence of intra-abdominal abscess or
collection.
There are concerns about the long-term outcome with
the PG procedure. Lemaire et al18 reported that patients
who underwent PD using the PG technique remained free
from diabetes but developed marked pancreatic exocrine
insufficiency during a median follow-up period of 32
months. Similarly, Pessaux et al19 reported the presence of
exocrine pancreatic insufficiency in 95% (18/19) of their
patients with PG during a mean follow-up period of 40.3
months. The possible explanation is that pancreatic enzy-
matic secretions can be neutralized by gastric acid. How-
ever, an RCT by Konishi et al20 demonstrated no difference
between PG and PJ. Regarding endocrine function, no dif-
ference was identified between these two reconstructions
in several reports.8,20,21 Ishikawa et al22 concluded that the
decline in glucose tolerance after PD seemed to be asso-
ciated with the low reserve of endocrine function rather
160 Y. Zhou et al.than the type of pancreatic anastomosis or associated
complications.
The current analysis showed no significant difference in
DGE between PJ and PG. Although some researchers re-
ported that DGE developed more frequently in patients
with postoperative complications such as PF, biliary fistula,
and intra-abdominal collections or abscesses,23 the results
are not confirmed by other investigators.24,25
There are some limitations with our study. Only one of
the six RCTs included in our meta-analysis focused on
patients at high risk of PF (with soft pancreas and a
diameter of the main duct <5 mm).5 Therefore, the
advantage of PG in such subgroup patients could not be
reliably assessed. Another limitation is that all six RCTs
were conducted in Western countries. This may raise a
question regarding the validity of the results and appli-
cability to other areas.
In conclusion, our meta-analysis has demonstrated that
PG following PD represents a safe procedure that is asso-
ciated with lower occurrences of PF compared with PJ.Acknowledgments
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